Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,550,490
Closed -$59.4M 8
2020
Q1
$59.4M Hold
6,550,490
10.57% 5
2019
Q4
$139M Hold
6,550,490
9.54% 6
2019
Q3
$150M Hold
6,550,490
8.82% 5
2019
Q2
$159M Hold
6,550,490
9.32% 6
2019
Q1
$84.9M Hold
6,550,490
4.97% 7
2018
Q4
$98.7M Hold
6,550,490
5.26% 9
2018
Q3
$258M Hold
6,550,490
11.91% 3
2018
Q2
$322M Hold
6,550,490
13.04% 3
2018
Q1
$391M Hold
6,550,490
13.59% 2
2017
Q4
$516M Buy
6,550,490
+641,100
+11% +$51.7M 18.31% 1
2017
Q3
$496M Buy
5,909,390
+2,493,000
+73% +$177M 17.89% 1
2017
Q2
$223M Buy
3,416,390
+1,740,820
+104% +$118M 8.61% 3
2017
Q1
$122M Buy
+1,675,570
New +$110M 4.39% 10

Other funds holding ADNT

Blue Harbour Group's ADNT Position: Q2 2020 in Review

Blue Harbour Group sold out of Adient (ADNT) in Q2 2020, closing a stake of 6,550,490 shares — an estimated $59.4M sold.

Blue Harbour Group first reported a position in ADNT in Q1 2017 and held it in 13 quarters. The position peaked at $516M in Q4 2017. 284 funds tracked by Wall St. Rank hold ADNT as of Q2 2020.

  • Blue Harbour Group reported no remaining Adient position as of Q2 2020 after selling out during the quarter.
  • Blue Harbour Group sold 6,550,490 Adient shares in Q2 2020, an estimated $59.4M.
  • Blue Harbour Group first reported a position in Adient in Q1 2017 and held it in 13 quarters.
  • Blue Harbour Group's Adient position peaked at $516M in Q4 2017.
  • 284 funds tracked by Wall St. Rank held Adient as of Q2 2020.

Based on Blue Harbour Group's 13F filing for Q2 2020, filed 31 Jul 2020.